SEATTLE
Citalopram, a medication commonly prescribed to children with autism spectrum disorders (ASD), was no more effective than a placebo at reducing repetitive behaviors, according to researchers funded by the National Institute of Mental Health (NIMH) and other NIH institutes. The study was published in the June 2009 issue of Archives of General Psychiatry.
JUNE 1, 2009, SEATTLE ? Soccer players and exercise enthusiasts now have another reason to reach for lowfat chocolate milk after a hard workout, suggests a new study from James Madison University presented at the American College of Sports Medicine annual meeting.
A study led by sports medicine researcher Anne Hoch, D.O., at The Medical College of Wisconsin in Milwaukee has revealed that young female professional dancers face the same health risks as young female athletes when they don't eat enough to offset the energy they spend, and stop menstruating as a consequence.
Washington, DC ? The cardiovascular fitness level of cancer survivors is not affected by many standard cancer therapies, say researchers from Georgetown University Medical Cancer. That is the finding of a new observational study to be presented today at the American College of Sports Medicine in Seattle.
SEATTLE, Wash., May 28, 2009, ? Drinking cherry juice could help ease the pain for people who run, according to new research from Oregon Health & Science University presented at the American College of Sports Medicine Conference in Seattle, Wash.
Seattle ? Non-invasive imaging can measure how well patients with the most common form of breast cancer - estrogen receptor positive type - respond to standard aromatase inhibitor therapy after only two weeks and shows similar findings that more invasive needle sampling identifies, according to a poster presentation to be presented at the ASCO annual meeting next week.
Using Positron Emis
Dr. Jared Strote at the University of Washington Medical Center led a group that examined the medical records of nearly 900 patients subdued by the Seattle Police Department with a Taser over a six-year period. Less than one percent required hospital admission for an injury related to the restraint incident. No deaths occurred, even when patients exhibited signs of excited delirium.
STANFORD, Calif. - HIV-positive patients who don't seek medical attention until they have a serious AIDS-related condition can reduce their risk of death or other complications by half if they get antiretroviral treatment early on, according to a new multicenter trial led by researchers at the Stanford University School of Medicine.
It's a curious paradox. Black adults are more likely to smoke than white adults and most smokers start as teenagers. But statistics show that fewer black youths than whites begin smoking as adolescents.
A recently completed international multi-center clinical trial has found that acyclovir, a drug widely used as a safe and effective treatment to suppress herpes simplex virus-2 (HSV-2), which is the most common cause of genital herpes, does not reduce the risk of HIV transmission when taken by people infected with both HIV and HSV-2.
Boulder, CO, USA - Hot topics include (1) opposition to the idea that chevron-shaped dunes are indicative of mega-tsunamis; (2) discovery of a complex microbial community that extends the fossil record of cavity-dwelling life by more than 1.5 billion years; (3) documentation of nanoscale, respirable cristobalite fibers in volcanic ash from Chaiten volcano and the likely adverse health effects;
St. Louis, MO, May 1, 2009 - As people become more educated, studies have demonstrated that they tend to choose foods that are lower in calories but higher in nutrients. They also pay more.
For 2.7 million Americans with epilepsy, seizures are not the only concern. People with epilepsy frequently face mood and behavior challenges and side effects from their medications, such as sleep and cognition problems.
SEATTLE, WA - April 30, 2009 - Biogen Idec (NASDAQ: BIIB) today announced data results from the CHAMPIONS (Controlled High-Risk AVONEX(R) (interferon beta-1a) Multiple Sclerosis (MS) Prevention Study In Ongoing Neurologic Surveillance) study, an open label follow-up to CHAMPS (Controlled High Risk Subjects AVONEX MS Prevention Study).
SEATTLE - Using a steroid drug for multiple sclerosis (MS) in addition to an MS drug may reduce the amount of disease activity more than using the MS drug alone, according to a study that will be presented as part of the Late-breaking Science Program at the American Academy of Neurology's 61st Annual Meeting in Seattle, April 25 - May 2, 2009.
